Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The I.I. Mechnikov Research Institute of Vaccines and Sera is a premier Russian scientific institution specializing in microbiology, virology, and immunology. Founded in 1919 and headquartered in Moscow, the institute is a critical component of the national healthcare infrastructure, focusing on the development and production of immunobiological preparations. Its extensive portfolio includes vaccines for influenza, diphtheria, and tetanus, as well as therapeutic immunoglobulins and diagnostic test kits for infectious diseases. Beyond manufacturing, the institute conducts cutting-edge research in molecular biology, focusing on the mechanisms of immunity and the creation of next-generation vaccine delivery systems. It operates as a major hub for clinical and experimental studies in the Eurasian region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mechnikov Research Institute of Vaccines and Sera.